Tower Research Capital (TRC)’s Monogram Orthopaedics MGRM Stock Holding History

Tower Research Capital (TRC)’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,131	Closed	-$6.64K	–	5419
2025 Q3	$6.64K	Sell	1,131 -384	-25%	-$2.05K	﹤0.01%	4148
2025 Q2	$4.38K	Buy	1,515 +233	+18%	+$628	﹤0.01%	4335
2025 Q1	$3.77K	Sell	1,282 -689	-35%	-$1.82K	﹤0.01%	4355
2024 Q4	$4.67K	Sell	1,971 -23	-1%	-$54	﹤0.01%	4419
2024 Q3	$5.28K	Sell	1,994 -1,795	-47%	-$4.67K	﹤0.01%	4295
2024 Q2	$8.15K	Sell	3,789 -734	-16%	-$1.61K	﹤0.01%	4388
2024 Q1	$11K	Buy	+4,523	New	+$13.3K	﹤0.01%	3612

Tower Research Capital (TRC)'s MGRM Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 1,131 shares — an estimated $6.64K sold.

Tower Research Capital (TRC) first reported a position in MGRM in Q1 2024 and held it in 7 quarters. The position peaked at $11K in Q1 2024. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Tower Research Capital (TRC) reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,131 Monogram Orthopaedics shares in Q4 2025, an estimated $6.64K.
Tower Research Capital (TRC) first reported a position in Monogram Orthopaedics in Q1 2024 and held it in 7 quarters.
Tower Research Capital (TRC)'s Monogram Orthopaedics position peaked at $11K in Q1 2024.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.